SCOTUS Blocks Lower-Court Restriction on Abortion Pill Access
The Court said a 2023 FDA rule allowing people to access mifepristone via telehealth and at a pharmacy could remain in place while the lawsuit plays out in a federal appeals court.
The Court said a 2023 FDA rule allowing people to access mifepristone via telehealth and at a pharmacy could remain in place while the lawsuit plays out in a federal appeals court.
Find verified resources for reproductive healthcare, support services, and advocacy organizations.
Find Resources